Log in | Register

Pre-Validated Pharmaceutical Water Distribution Systems

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Pre-Validated Pharmaceutical Water Distribution Systems

NEXUS® is a range of standard, packaged, pre-validated distribution systems for purified water and water for injection for flow rates up to 30m3/h (132 USgpm). Each package is complete with a booster pump, 316L stainless steel pipe work (ASME BPE as optional), double tube sheet heat exchanger and control panel. The hygienic design and fabrication in 316L stainless steel are fully compliant with GAMP, ISPE, cGMP and FDA requirements. To ensure continuous water quality and quantity, NEXUS® comes with conductivity monitoring, temperature control and loop flow meter (options for TOC and ozone monitoring). NEXUS® offers a choice of sanitization methods by either using state of-the-art electrolytically generated ozone with UV ozone destruction, or hot water at 85°C/185°F (121 °C/249°F for WFI). Both sanitization solutions are recommended within the pharmaceutical industry for their sanitizing effect efficiency and consistency throughout time. Every NEXUS® unit is supplied with a full standardized validation pack, including Functional Design Specification, Design Qualification, Installation Qualification and Factory Acceptance Test documentation which gives peace of mind for the project and quality engineers.

Veolia Water Solutions & Technologies, Paris, France. www.pharma.veoliawaterst.com

Register or log in to send e-mail for more info

E-mail to a colleague

See company's other products

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter